KFDA orders sales suspension for Novartis' famvir cream

The government said on July 25 that it banned the sales of Novartis Korea's Famvir (famciclovir) and Dongyang Pharm's cimetiidne and famotidine for six months on grounds of their failure to submit related documents for this year's drug re-evaluation program.

The Korea Food and Drug Administration also instructed Bukwang Pharm to recall Holoxan injection, following reports of impurity contain...